The molecular characterization of the first example of null allele in the inter-alpha-trypsin inhibitor H1 (ITIH1) system, ITIHI* QOiwate, encountered as apparent inverse homozygosity of ITIH 1 phenotypes between mother and child in a paternity case, is described. Single-strand conformation polymorphism analysis and subsequent sequencing showed that deletion of a single nucleotide in the codon for Lys 8r results irfa frameshift causing a terminator codon downstream of the deletion. This leads to premature termination of ITIH1 protein translation at amino acid 128, resulting in a truncated protein.
Inter-alpha-trypsin inhibitor (ITI) is a plasma serine protease inhibitor consisting of two heavy chains, ITIH1 and ITIH2, and one light chain, ITIL (Enghild et al., 1989) , for which the structural genes are located on chromosome 3p211-p212, 10p13 and 9q32-33, respectively (Diarra-Mehrpour et al., 1989) . The function of the heavy chains is not clear, but is likely to play a role of carrier protein as a regulator for hyaluronan (Huang et al., 1993) . The genetic polymorphism of plasma ITI has been described by isoelectric focusing (IEF) and immunostaining techniques (Vogt and Cleve, 1990; Vogt et al., 1991a; Yuasa et al., 1991; Harada et al., 1994) and has been revealed to arise from the variation for the ITIH1 chain by Southern hybridization analysis (Vogt et al., 1994) and by an immunological assay with three monoclonal antibodies for each chain (Harada et al., 1995) . The ITIHI chain is composed of 877 amino acid residues with a molecular mass of 92 kDa (Diarra-Mehrpour et al., 1992) . The ITIHI gene spans about 14 kb and includes 22 exons with 15-281 bp in size (Bost et al., 1993) . Three common alleles, ITIHI* 1, ITIHI*2 and ITIHI*3, are characterized by amino acid substitutions at positions 551 and 561 in exon 14 (Ding et al., 1995a) .
We previously reported a paternity case showing an inverse homozygosity between a mother (ITIH1 2) and her child (ITIHI I). However, no incompatible results were found in the other polymorphic markers including several DNA polymorphic systems. In addition, they have shared a rare alpha-2-HS-glycoprotein allele, AHSG*15 (Nakayashiki et al., 1994) . We suspected that they shared an ITIH 1 null allele, tentatively designated ITIHI* QOiwate, responsible for TTGGAGGTACAGGGGGTTG  CAGGATGGGGAACAGTG  TGGATGGTGAGGTAGGCCC  GTCGATGGTGGGCTTCAGGC  GTGGAGTCAGGGAAGAATGG  ACGGAGGAAGAAAGCCAACG  AGCTAGGCAGGTCCCAGAGA   56  244  52  318  58  152  64  203  58  195  58  150  60  260   TAGTCCTGTCCTGGCTGA  52  208  CACACACCTCCCCCTGCATC-64  268  TT  CAGCACATAGAAGCCCAGGA-62  191  AG  AGGAAGCTCACCCCACCCAT-64  232  GT  TCCTCCTCCTCTGCCTTGG  58 227 T, annealing temperature; underline shows region overlapping to exon sequence. their incompatibility. In this study the ITIHI*QO~w~t~ was investigated by polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis and direct sequencing.
Genomic DNAs were prepared from whole blood of the members of a family (parents and child) and healthy Japanese volunteers, whose plasma ITIH 1 phenotypes were known. Oligonucleotide primer pairs for the amplification of 22 exons were designed from genomic sequence of ITIH1 gene (Bost et al., 1993) as shown in Table 1 . Each exon was amplified by PCR mostly according to Thiberville et al. (1994) . The PCR products of each exon were subjected to SSCP analysis as described by Ding et al. (1995a) . Some target fragments showing an altered migration pattern were excised from a gel, amplified by the second PCR and then purified for direct sequencing. Sequencing was carried out using the forward and reverse primers of the corresponding fragment in an autosequencer (373A DNA sequencer, Applied Biosystems).
Each exon was successfully amplified by PCR and the sizes of each fragment were consistent with ones expected from primer designs and the genomic sequence. SSCP analysis showed altered migration patterns in some exons including exons 4 and 14. As shown in Fig. 1 , the mother and child were distinguishable in the SSCP pattern of exon 4 from other individuals with common ITI phenotypes. In the SSCP analysis of exon 14 which characterizing three common alleles (Ding et al., 1995a) , the mother (ITIH1 2-Q01wate) and child (ITIHI 1-Q01wate) were typed as ITIH1 2-1 and ITIH1 1, respectively (data not shown). Therefore, we hypothesize that the ITIHI*QO~wat~ is a derivative of ITIHI*I. Direct sequencing of amplified fragment of exon 4 from the mother and child revealed a deletion of the third nucleotide (guanine) of the codon for Lys 87 (Fig. 2) . This deletion results in a frameshift causing a terminator codon at position 128 in exon 5, leading to a truncated protein (Fig. 3) . This protein is probably unstable, because it consists of only 127 amino acids, /.e., about 15% of the mature protein, and is predicted to have an alternative carboxyI terminus (amino acids 87-127). Even if it were expressed in blood, the antigenic epitopes to commercially available polyclonal anti-human ITI antibody would be highly or completely lost. In this study, 22 pairs of primers were prepared to analyze every coding exons of ITIH1 gene. Some of primers contained nucleotide sequences of coding regions (Table 1) , because of the limited genomic sequence data (Bost et al., 1993) . Only a few short regions of coding exons and a Y-flanking region were not analyzed.
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Though possible mutations in the unexamined regions were not denied, we supposed that the deletion of a guanine residue resulting in a terminator codon is a cause to form the ITIHl*QO~wate. The mother and child in this case were apparently healthy, suggesting that there are no clinical problems in a heterozygous state of ITIHl*QO~wate. It would be of much interest to know clinical influence and structural effect to ITI molecule in a homozygous state. Vogt et al. (1991b) observed the significant increase of homozygotes in 81 tested children under 18 months and described that the incomplete expression of ITI heterozygous phenotypes in younger children might raise incorrect typing as homozygous ones. On the other hand, Ding et al. (1995b) investigated 79 newborns to compare the phenotypes by IEF of chondroitinase ABC-treated plasma ITIH1 with those by SSCP analysis of PCR products of exon 14, and concluded that there are no incompatible cases. In this study, we present the evidence for the existence of a null allele in the ITIH1 systems, so that attentions must be paid in conventional ITIH1 phenotyping of plasma samples. To dissolve such problems, PCR-SSCP typing of exon 4 and 14 should be useful for accurate ITIHI genotyping.
